Kindeva Drug Delivery, a global drug-device combination product CDMO, is expanding its Loughborough, UK facilities at the Charnwood Campus Science Innovation and Technology Park. This strategic move supports the growth of green propellant commercialization and secures a dedicated space for the company’s commercial analytical lab services team who will be housed at this location once renovations are completed later this year.
Kindeva Drug Delivery Expands Loughborough, UK, Facilities at Charnwood Campus to Support Growth of Green Propellant Commercialization
Kindeva Global Health Security Donates ATNAA to Ukraine Through the European Commission's rescEU and Governmental Strategic Reserves Agency (RARS)
Kindeva Drug Delivery, a global provider of drug-device combination products, has invested in a second manufacturing line for the production of pressurized metered-dose inhaler (pMDI) products containing low-GWP (Global Warming Potential) propellants in its Loughborough, U.K., facility.
Kindeva`s John Patton Wins RDD Conference Charles G Thiel Award
John Patton, Head of Kindeva Drug Delivery’s Scientific Advisory Board, Named Winner of RDD Conference’s Charles G. Thiel Award
WOODBURY, Minn. & ST. LOUIS--(BUSINESS WIRE)--Kindeva Drug Delivery (Kindeva), a global leader in drug-device combination products, today announced its investment in a second manufacturing line for the production of pressurized metered-dose inhaler (pMDI) products containing low-GWP (Global Warming Potential) propellants in its Loughborough, U.K., facility.
Denis Johnson Joins Kindeva Drug Delivery as Chief Operating Officer to Lead Global Operations
Kindeva Drug Delivery announced today that it appointed Denis Johnson as its new chief operating officer (COO).
Kindeva Drug Delivery and Syntegon install first Versynta microBatch in NA